The goal of this clinical trial is to learn if a kidney transplant-specific comprehensive geriatric assessment (KT-CGA) can improve the way older adults are assessed for kidney transplantation. The main questions it aims to answer are: Is it feasible and acceptable to deliver a KT-CGA alongside routine transplant assessment in older adults with advanced kidney disease? What is the effect of KT-CGA on decision-making about transplant listing and on patient-reported outcomes such as quality of life and frailty? Researchers will compare participants who receive the KT-CGA plus usual care to those who receive usual care alone. Participants will: Continue with their usual transplant assessment process If randomised to the intervention group, also complete the KT-CGA (a structured set of questionnaires, short memory and function tests, and discussions about wellbeing and support needs, taking about 45-60 minutes)
Age range
60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Proportion of eligible patients who consented and were randomised
Timeframe: From first eligible patient approached through completion of recruitment (anticipated 12 months)
Proportion of participants allocated to KT-CGA who completed the full assessment
Timeframe: At intervention visit (single study visit following randomisation, within 4 weeks of allocation)
Duration of KT-CGA visit
Timeframe: At intervention visit (single study visit following randomisation, within 4 weeks of allocation)
Reach of KT-CGA
Timeframe: From first intervention delivered through completion of recruitment (anticipated 12 months)
Fidelity of KT-CGA delivery
Timeframe: At intervention visit (single study visit following randomisation, within 4 weeks of allocation)
Participant acceptability of randomisation and KT-CGA
Timeframe: Immediately post-intervention visit (same day as KT-CGA visit)